Key result
Clinical registries and randomized controlled trials each have distinct advantages, and their joint use can improve the efficiency and generalizability of cardiovascular research.
Answers are grounded in this paper and cite their sources.
Combining clinical registries with randomized controlled trials offers a pragmatic approach to generate robust, generalizable, and cost-effective evidence in cardiology.
Clinical registries are established as tools for auditing clinical standards and benchmarking quality improvement initiatives. They also have an emerging role (as electronic health records) in cardiovascular research and, in particular, the conduct of RCTs. While the RCT is accepted as the most robust experimental design, observational data from clinical registries has become increasingly valuable for RCTs. Data from clinical registries may be used to augment results from RCTs, identify patients for recruitment and as an alternative when randomization is not practically possible or ethically desirable. Here the authors appraise the advantages and disadvantages of both methodologies, with the aim of clarifying when their joint use may be successful.
No takes yet. Share an insight, caveat, or question.
Ieva et al. (2014) conducted a review in Cardiovascular disease. Clinical registries vs. Randomized controlled trials was evaluated. Clinical registries and randomized controlled trials each have distinct advantages, and their joint use can improve the efficiency and generalizability of cardiovascular research.
Synapse has enriched 10 related papers. Consider them for comparative context: